Golden State Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$71.8K Sell
918
-1,985
-68% -$160K 0.01% 644
2026
Q1
$252K Buy
2,903
+1,994
+219% +$191K 0.03% 354
2025
Q4
$87.3K Sell
909
-70
-7% -$6.8K 0.01% 552
2025
Q3
$93.2K Buy
979
+7
+0.7% +$643 0.01% 523
2025
Q2
$84.7K Sell
972
-45
-4% -$3.82K 0.01% 527
2025
Q1
$91.4K Buy
1,017
+37
+4% +$3.31K 0.01% 468
2024
Q4
$78.3K Buy
+980
New +$84.8K 0.01% 477
2022
Q1
Sell
-2,817
Closed -$291K 338
2021
Q4
$291K Buy
+2,817
New +$326K 0.05% 288
2021
Q1
Sell
-2,912
Closed -$341K 223
2020
Q4
$341K Buy
2,912
+1,576
+118% +$173K 0.1% 161
2020
Q3
$139K Sell
1,336
-4,054
-75% -$407K 0.05% 231
2020
Q2
$494K Buy
5,390
+4,380
+434% +$420K 0.13% 122
2020
Q1
$91K Buy
+1,010
New +$107K 0.04% 262
2019
Q4
Sell
-812
Closed -$88K 581
2019
Q3
$88K Buy
812
+81
+11% +$8.45K 0.03% 331
2019
Q2
$71K Hold
731
0.02% 389
2019
Q1
$67K Buy
+731
New +$65.4K 0.02% 386

Other funds holding MDT

Golden State Wealth Management's MDT Position: Q2 2026 in Review

Golden State Wealth Management reduced its Medtronic (MDT) stake by 68% in Q2 2026, selling an estimated $160K and leaving 918 shares worth $71.8K. The position accounts for 0.01% of the portfolio, ranked #644.

Golden State Wealth Management first reported a position in MDT in Q1 2019 and has held it in 15 quarters since. The position peaked at $494K in Q2 2020. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Golden State Wealth Management held 918 shares of Medtronic worth $71.8K as of Q2 2026.
  • Golden State Wealth Management sold 1,985 Medtronic shares in Q2 2026, an estimated $160K.
  • Medtronic made up 0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #644 holding.
  • Golden State Wealth Management first reported a position in Medtronic in Q1 2019 and has held it in 15 quarters since.
  • Golden State Wealth Management's Medtronic position peaked at $494K in Q2 2020.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.